ML-93
ML-93 is an orally active SAE inhibitor, with an IC50 value of 0.4 μM. ML-93 inhibits the SUMOylation pathway in HCT116 cells. ML-93 shows robust antitumor activity in the HCT116 colorectal carcinoma xenograft model. ML-93 can be used for the study of colorectal cancer[1].
Product Specifications
CAS Number
1858275-91-8
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
CC1=C(C=C(S1)C(C2=CN=CN=C2N[C@@H]3C[C@@H]([C@H](C3)O)COS(N)(=O)=O)=O)[C@H]4C5=CC(Cl)=CC=C5CCO4
Molecular Formula
C25H27ClN4O6S2
Molecular Weight
579.09
References & Citations
[1]Langston SP, et al. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer. J Med Chem. 2021 Mar 11;64 (5) :2501-2520.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3112944 100 µg
HEC1/HEC/NDC80 Rabbit Polyclonal Antibody (Fluoro488)
Sign In for Pricing
View Details MBS6226581-01 0.1 mL
ASB5 (Ankyrin Repeat and SOCS Box-Containing 5) (MaxLight 650)
Sign In for Pricing
View Details MBS6226581-02 5x 0.1 mL
ASB5 (Ankyrin Repeat and SOCS Box-Containing 5) (MaxLight 650)
Sign In for Pricing
View Details